The new study published in The New England Journal of Medicine demonstrated that the compound in Mounjaro and Zepbound decreased the risk of diabetes by 94% in overweight adults with pre-diabetes.
Most patients on these medications managed to maintain their blood sugar levels within normal ranges after a three-year period, indicating a significant potential for these drugs in preventing diabetes.
However, some healthcare professionals caution against using these drugs as first-line treatments, emphasizing that diet and exercise might often yield effective results for managing pre-diabetes.
Dr. Kristina Henderson Lewis pointed out that while these medications are potent, lifestyle changes or less expensive alternatives might suffice for many individuals, raising concerns about necessity and accessibility.
Collection
[
|
...
]